SINGAPORE - The private equity specialist credited with transforming Singapore-based Fullerton Healthcare Corp (FHC) into an Asia-Pacific healthcare management firm is embroiled in a legal spat with his two partners in relation to its potential billion-dollar equity sale.
Mr David Sin, a co-founder, group president and executive director of FHC, is suing co-founders and minority shareholders Michael Tan and Daniel Chan, two former Parkway doctors.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
